全球酒精使用疾患市場：區域與國家分析與預測（2025-2035年）

全球酒精使用疾患市場目前正處於生命週期的成長階段。

這一階段的特點是創新治療方法的需求不斷成長，酒精使用疾患被認可為重大公共衛生問題。個人化醫療的進步（根據個人基因圖譜最佳化治療方法）和新的、更有效和更有針對性的藥物療法的開發推動市場成長。此外，整合藥物治療和行為療法的綜合治療模式的廣泛採用也促進了市場擴張。此外，遠端醫療和線上支援平台等數位健康技術的日益普及，改善酒精使用疾患治療的可近性，特別是在服務欠缺地區。全球加強成癮治療醫療基礎設施的運動也在不斷發展，這有助於擴大治療的範圍和可用性。儘管存在這些機會，但治療費用高昂和對成癮的社會恥辱等挑戰依然存在，這些挑戰阻礙了治療方法的廣泛採用，特別是在開發中國家。儘管如此，隨著透過公共衛生宣傳活動提高認知和改善治療途徑，預計未來市場將進一步成長並進入更成熟的階段。

影響

• 預計預測期內，對酒精使用疾患治療的需求不斷成長將推動全球市場的成長
• 標靶治療的進步、認知和診斷的提高、臨床管道的擴大、醫療保健基礎設施的改善以及獲得專門治療的機會預計將成為推動市場發展的關鍵驅動力。

最新動態

• 研究活動：2025年 5月，Adial Pharmaceuticals, Inc. 宣布美國專利商標局已授予專利號 12,274,692，涵蓋使用 AD04 治療基因定義的患者群體中的酒精相關和鴉片類藥物相關疾病的創新方法。

本報告調查了全球酒精使用疾患市場，並總結了主要趨勢、市場影響因素分析、法律制度、臨床試驗趨勢、市場規模趨勢和預測、各個細分市場、地區/主要國家的詳細分析、競爭格局和主要企業的概況。

目錄

執行摘要

第1章 全球酒精使用疾患市場：產業展望

• 市場概況與生態系統
• 市場趨勢
• 酒精使用疾患的流行病學分析
  • 依地區
• 臨床試驗
  • 依階段
  • 依贊助商類型
• 監管狀況/合規性
  • 美國法律要求與框架
  • 歐盟法律要求和框架
  • 亞太地區的法律要求與框架
• 市場動態
  • 影響分析
  • 市場促進因素
  • 市場限制
  • 市場機會

第2章 全球酒精使用疾患市場（依地區）

• 北美洲
• 歐洲
• 亞太地區
  • 市場動態
  • 市場規模及預測

第3章 全球酒精使用疾患市場：競爭基準化分析與公司簡介

• 競爭格局
  • 各公司主要策略及發展
  • 主要發展分析
• 公司簡介
  • Clearmind Medicine Inc.
  • Purdue Pharma LP
  • Psyence Biomedical
  • Eli Lilly and Company
  • Tempero Bio, Inc.
  • Nxera Pharma Co., Ltd.
  • Novo Nordisk A/S
  • Adial Pharmaceuticals
  • Alkermes
  • Lundbeck

第4章 調查方法

Market Lifecycle Stage

The global alcohol use disorder market is currently in the growth stage of its lifecycle. This phase is characterized by a rising demand for innovative treatments and increased recognition of alcohol use disorder as a significant public health issue. The market is benefiting from advancements in personalized medicine, where treatments are tailored to individuals based on genetic profiles, as well as the development of new pharmacotherapies that offer more effective and targeted solutions. Additionally, the market is being driven by the growing integration of behavioral therapies with pharmacological treatments, creating more comprehensive and effective care models. Another key factor in the market's growth is the increasing adoption of digital health technologies, including telemedicine and online support platforms, which make alcohol use disorder treatments more accessible, especially in underserved regions. This is coupled with a global push for better addiction treatment infrastructure, expanding both the reach and availability of care. Despite these opportunities, challenges such as high treatment costs and social stigmas related to addiction still persist, especially in developing markets, potentially limiting the broader adoption of treatment solutions. However, as public health initiatives continue to promote awareness and access, the market is expected to grow further and move toward a more mature stage in the coming years.

Impact

• Increasing demand for alcohol use disorder therapies is anticipated to support the growth of the global alcohol use disorder market during the forecast period 2025-2035.
• The global alcohol use disorder market is expected to grow at a significant rate due to developments in targeted therapies, rising awareness and diagnosis, and a growing clinical pipeline, alongside advancements in healthcare infrastructure and access to specialized treatments.

Recent Developments

• Research Activities: In May 2025, Adial Pharmaceuticals, Inc. announced that the U.S. Patent and Trademark Office had issued U.S. Patent No. 12,274,692, covering an innovative method for treating alcohol-related and opioid-related disorders using AD04 in genetically defined patient populations.

Demand - Drivers and Limitations

Drivers:

• Increasing Prevalence of Alcohol Use Disorder
• Improved Diagnostic Criteria and Screening Tools

Limitations:

• Limited Treatment Options for Specific Populations

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: Innovations in the global alcohol use disorder market are centered on advancing treatment options to enhance patient care. Key players in the market, such as Adial Pharmaceutical, Inc., have been involved in the development of therapies for alcohol use disorder.

Competitive Strategy: Enterprises led by market leaders continually update their product portfolios with innovative treatments to maintain competitiveness. A detailed competitive benchmarking of the key players has been conducted, providing insights into how these companies compare in terms of product pipeline and innovation. This benchmarking provides readers with a clear understanding of the market landscape and the positions of the leading players. Additionally, comprehensive competitive strategies, such as partnerships, agreements, and collaborations, will help readers identify untapped revenue opportunities in the market.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and by analyzing company coverage, product portfolios, and market penetration.

Some of the prominent names established in this market are:

• Clearmind Medicine Inc.
• Purdue Pharma L.P.
• Psyence Biomedical
• Eli Lilly and Company
• Tempero Bio, Inc.
• Nxera Pharma Co., Ltd.
• Novo Nordisk A/S
• Adial Pharmaceuticals
• Alkermes
• Lundbeck

Table of Contents

Executive Summary

Scope of Study

1. Global Alcohol Use Disorder Market: Industry Outlook

• 1.1 Market Overview and Ecosystem
• 1.2 Market Trends
• 1.3 Epidemiological Analysis of Alcohol Use Disorder
  • 1.3.1 By Region
• 1.4 Clinical Trials
  • 1.4.1 By Phase
  • 1.4.2 By Sponsor Type
• 1.5 Regulatory Landscape / Compliance
  • 1.5.1 Legal Requirement and Framework in the U.S.
  • 1.5.2 Legal Requirement and Framework in the E.U.
  • 1.5.3 Legal Requirement and Framework in Asia-Pacific
• 1.6 Market Dynamics
  • 1.6.1 Impact Analysis
  • 1.6.2 Market Drivers
  • 1.6.3 Market Restraints
  • 1.6.4 Market Opportunities

2. Global Alcohol Use Disorder Market, By Region, $Million, 2023-2035

• 2.1 North America
  • 2.1.1 Market Dynamics
  • 2.1.2 Market Size and Forecast
    • 2.1.2.1 North America Alcohol Use Disorder Market (by Country)
      • 2.1.2.1.1 U.S.
• 2.2 Europe
  • 2.2.1 Market Dynamics
  • 2.2.2 Market Size and Forecast
    • 2.2.2.1 Europe Alcohol Use Disorder Market (by Country)
      • 2.2.2.1.1 U.K.
      • 2.2.2.1.2 Germany
      • 2.2.2.1.3 France
      • 2.2.2.1.4 Italy
      • 2.2.2.1.5 Spain
• 2.3 Asia-Pacific
  • 2.3.1 Market Dynamics
  • 2.3.2 Market Size and Forecast
    • 2.3.2.1 Asia-Pacific Alcohol Use Disorder Market (by Country)
      • 2.3.2.1.1 Japan

3. Global Alcohol Use Disorder Market - Competitive Benchmarking and Company Profiles

• 3.1 Competitive Landscape
  • 3.1.1 Key Strategies and Developments by Company
    • 3.1.1.1 Funding Activities
    • 3.1.1.2 Mergers and Acquisitions
    • 3.1.1.3 Regulatory Approvals
    • 3.1.1.4 Partnerships, Collaborations and Business Expansions
  • 3.1.2 Key Developments Analysis
• 3.2 Company Profiles
  • 3.2.1 Clearmind Medicine Inc.
    • 3.2.1.1 Company Overview
    • 3.2.1.2 Product Portfolio
    • 3.2.1.3 Target Customers/End Users
    • 3.2.1.4 Analyst View
  • 3.2.2 Purdue Pharma L.P.
    • 3.2.2.1 Company Overview
    • 3.2.2.2 Product Portfolio
    • 3.2.2.3 Target Customers/End Users
    • 3.2.2.4 Analyst View
  • 3.2.3 Psyence Biomedical
    • 3.2.3.1 Company Overview
    • 3.2.3.2 Product Portfolio
    • 3.2.3.3 Target Customers/End Users
    • 3.2.3.4 Analyst View
  • 3.2.4 Eli Lilly and Company
    • 3.2.4.1 Company Overview
    • 3.2.4.2 Product Portfolio
    • 3.2.4.3 Target Customers/End Users
    • 3.2.4.4 Analyst View
  • 3.2.5 Tempero Bio, Inc.
    • 3.2.5.1 Company Overview
    • 3.2.5.2 Product Portfolio
    • 3.2.5.3 Target Customers/End Users
    • 3.2.5.4 Analyst View
  • 3.2.6 Nxera Pharma Co., Ltd.
    • 3.2.6.1 Company Overview
    • 3.2.6.2 Product Portfolio
    • 3.2.6.3 Target Customers/End Users
    • 3.2.6.4 Analyst View
  • 3.2.7 Novo Nordisk A/S
    • 3.2.7.1 Company Overview
    • 3.2.7.2 Product Portfolio
    • 3.2.7.3 Target Customers/End Users
    • 3.2.7.4 Analyst View
  • 3.2.8 Adial Pharmaceuticals
    • 3.2.8.1 Company Overview
    • 3.2.8.2 Product Portfolio
    • 3.2.8.3 Target Customers/End Users
    • 3.2.8.4 Analyst View
  • 3.2.9 Alkermes
    • 3.2.9.1 Company Overview
    • 3.2.9.2 Product Portfolio
    • 3.2.9.3 Target Customers/End Users
    • 3.2.9.4 Analyst View
  • 3.2.10 Lundbeck
    • 3.2.10.1 Company Overview
    • 3.2.10.2 Product Portfolio
    • 3.2.10.3 Target Customers/End Users
    • 3.2.10.4 Analyst View

4. Research Methodology

List of Figures

• Figure: Global Alcohol Use Disorder Market, Market Overview
• Figure: Global Alcohol Use Disorder Market Coverage
• Figure: Global Alcohol Use Disorder Market Key Trends, Impact Analysis, 2023-2035
• Figure: Global Alcohol Use Disorder Market, Competitive Landscape, January 2022-April 2025

List of Tables

• Table: Global Alcohol Use Disorder Market, Regulatory Scenario
• Table: Global Alcohol Use Disorder Market Dynamics, Impact Analysis